Nicla A Varnier1, Franzisca Pettit2, David Rees3, Steven Thou1, Mark Brown2, Amanda Henry4. 1. Department of Women's and Children's Health, St George Hospital, Kogarah, NSW, Australia. 2. Department of Renal Medicine, St George Hospital, Kogarah, NSW, Australia; School of Medicine, University of New South Wales, Sydney, Australia. 3. Department of Cardiology, St George Hospital, Kogarah, NSW, Australia. 4. Department of Women's and Children's Health, St George Hospital, Kogarah, NSW, Australia; School of Medicine, University of New South Wales, Sydney, Australia.
Abstract
BACKGROUND: Cardiovascular disease affects 0.2-4% of pregnancies. Coupled with the physiological stress of pregnancy, cardiovascular disease may present significant management challenges including appropriate risk:benefit analysis of medical and surgical management options. CASE: A 33-year-old gravida 4 para 1 miscarriage 2 presented at 18 weeks' gestation to the high-risk pregnancy service with a history of coronary artery disease and homozygous familial hypercholesterolaemia. Pre-pregnancy echocardiogram showed probable aortic xanthoma and preserved cardiac function. Prior to planned interventional cardiology assessment for her coronary artery disease she became pregnant, taking aspirin and multivitamins only. She had exertional angina responsive to metoprolol, agreed to recommencing statin therapy when serum cholesterol worsened, but declined angiography during pregnancy. At 36 weeks' gestation, she had further angina symptoms but no acute coronary syndrome. Induction in the High Dependency Unit with elective assisted vaginal delivery of a healthy female infant (birthweight 2460 g) occurred at 37 weeks. She underwent triple-vessel coronary artery bypass postpartum, recovering well. CONCLUSION: Whilst this specific condition is rare, the increase in cardiovascular disease and cardiovascular risks in the obstetric population emphasises the need for clear, multidisciplinary management from the outset of pregnancy for these women.
BACKGROUND:Cardiovascular disease affects 0.2-4% of pregnancies. Coupled with the physiological stress of pregnancy, cardiovascular disease may present significant management challenges including appropriate risk:benefit analysis of medical and surgical management options. CASE: A 33-year-old gravida 4 para 1 miscarriage 2 presented at 18 weeks' gestation to the high-risk pregnancy service with a history of coronary artery disease and homozygous familial hypercholesterolaemia. Pre-pregnancy echocardiogram showed probable aortic xanthoma and preserved cardiac function. Prior to planned interventional cardiology assessment for her coronary artery disease she became pregnant, taking aspirin and multivitamins only. She had exertional angina responsive to metoprolol, agreed to recommencing statin therapy when serum cholesterol worsened, but declined angiography during pregnancy. At 36 weeks' gestation, she had further angina symptoms but no acute coronary syndrome. Induction in the High Dependency Unit with elective assisted vaginal delivery of a healthy female infant (birthweight 2460 g) occurred at 37 weeks. She underwent triple-vessel coronary artery bypass postpartum, recovering well. CONCLUSION: Whilst this specific condition is rare, the increase in cardiovascular disease and cardiovascular risks in the obstetric population emphasises the need for clear, multidisciplinary management from the outset of pregnancy for these women.
Entities:
Keywords:
Cardiology; cardiovascular; drugs (medication); general medicine; high-risk pregnancy
Authors: W Palinski; F P D'Armiento; J L Witztum; F de Nigris; F Casanada; M Condorelli; M Silvestre; C Napoli Journal: Circ Res Date: 2001-11-23 Impact factor: 17.367
Authors: Anitha S John; Fionnuala Gurley; Hartzell V Schaff; Carole A Warnes; Sabrina D Phillips; Katherine W Arendt; Martin D Abel; Carl H Rose; Heidi M Connolly Journal: Ann Thorac Surg Date: 2011-04 Impact factor: 4.330
Authors: D Meeike Kusters; Hajar Hassani Lahsinoui; Joris A M van de Post; Albert Wiegman; Frits A Wijburg; John J P Kastelein; Barbara A Hutten Journal: Expert Rev Cardiovasc Ther Date: 2012-03
Authors: Vera Regitz-Zagrosek; Carina Blomstrom Lundqvist; Claudio Borghi; Renata Cifkova; Rafael Ferreira; Jean-Michel Foidart; J Simon R Gibbs; Christa Gohlke-Baerwolf; Bulent Gorenek; Bernard Iung; Mike Kirby; Angela H E M Maas; Joao Morais; Petros Nihoyannopoulos; Petronella G Pieper; Patrizia Presbitero; Jolien W Roos-Hesselink; Maria Schaufelberger; Ute Seeland; Lucia Torracca Journal: Eur Heart J Date: 2011-08-26 Impact factor: 29.983
Authors: Hans J Avis; Barbara A Hutten; Marcel Th B Twickler; John J P Kastelein; Joris A M van der Post; Anton F Stalenhoef; Maud N Vissers Journal: Curr Opin Lipidol Date: 2009-12 Impact factor: 4.776
Authors: Brian T Bateman; Sonia Hernandez-Diaz; Michael A Fischer; Ellen W Seely; Jeffrey L Ecker; Jessica M Franklin; Rishi J Desai; Cora Allen-Coleman; Helen Mogun; Jerry Avorn; Krista F Huybrechts Journal: BMJ Date: 2015-03-17